Harvard Apparatus Regenerative Technology (HRGN) Stock Statistics & Valuation Metrics

Harvard Apparatus Regenerative Technology has a market cap or net worth of $29.49M. The enterprise value is $27.64M.

Harvard Apparatus Regenerative Technology has 17,580,744 shares outstanding. The number of shares has decreased by -2.65% in one year.

Harvard Apparatus Regenerative Technology’s return on equity (ROE) is -6.50 and return on invested capital (ROIC) is -606.61%.

The current PE Ratio of Harvard Apparatus Regenerative Technology is ―. Harvard Apparatus Regenerative Technology’s PEG ratio is 0.23.

In the last 12 months, Harvard Apparatus Regenerative Technology had revenue of 0.00 and earned -6.87M in profits. Earnings per share was -0.42.

In the last 12 months, operating cash flow was -3.83M and capital expenditures 0.00, giving a free cash flow of -3.83M billion.

Harvard Apparatus Regenerative Technology pays an annual dividend of ―, resulting in a dividend yield of ―

Harvard Apparatus Regenerative Technology upcoming earnings date is May 18, 2026, Before Open (Confirmed).

Harvard Apparatus Regenerative Technology as a current ratio of 1.19, with Debt / Equity ratio of 18.83%

In the past 12 months, Harvard Apparatus Regenerative Technology has paid 0.00 in taxes.

Harvard Apparatus Regenerative Technology EV to EBITDA ratio is -3.84, with an EV/FCF ratio of -7.64.

Harvard Apparatus Regenerative Technology has $1.35M in cash and marketable securities with $199.00K in debt, giving a net cash position of $1.15M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Harvard Apparatus Regenerative Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―